- Product Details
Keywords
- 1-[4-(3-ethyl-7-morpholin-4-yltriazolo[4,5-d]pyrimidin-5-yl)phenyl]-3-[4-(4-methylpiperazine-1-carbonyl)phenyl]urea
- PKI-402 with high purity 99%
- PKI-402 in stock
Quick Details
- ProName: PKI-402
- CasNo: 1173204-81-3
- Appearance: Solid
- Application: pharmaceuticals
- DeliveryTime: in stock
- PackAge: 1g/bag, 5g/bag
- Port: wuhan
- Purity: 99%
- Storage: keep in tigh container
- Transportation: by air
- LimitNum: 0
- Related Substances: 0.5%Max
- Residue on Ignition: 0.5%Max
- Heavy Metal: 20ppm Max
- Valid Period: 3 months
Superiority
Wuhan Sunrise Technology Development Company limited(Wuhan Sunrise Pharmaceutical Tehcnology Co., Ltd) Wuhan Sunrise Technology Development Company limited is a high-tech pharmaceutical enterprise dedicated to R&D of chemical drug. The main business are R&D, technology transfer and technical services of APIs and pharmaceutical intermediates; R&D, manufacture and sales of PIs. Moreover, we have the right of dealing self-managed imp & exp business.
Main products:
Chemical synthesis series:
anti-cancer pharmaceutical intermediates,
ophthalmology APIs and related intermediates
Biological series: Mabs